1+ hour, 45+ min ago   (548+ words) The senior director of the Fluid Biomarker Program at Banner Health highlighted the evolving role of blood and fluid biomarkers in Alzheimer disease research and clinical practice. We also got some insights into therapeutics outside of the amyloid hypothesis. Looking…...

21+ hour, 14+ min ago   (150+ words) The research portfolio director at the Muscular Dystrophy Association spoke about ongoing advances in ALS research and how they may inform approaches to therapeutic development. [WATCH TIME: 5 minutes] WATCH TIME: 5 minutes | Captions are auto-generated and may contain errors. Abigail N. Schwaede,…...

1+ day ago   (116+ words) Abigail N. Schwaede, MD; Emmanuelle (Noelle) Tiongson, MD Shamik Bhattacharyya, MD, MS, FAAN; Mirla Avila, MD; Dean Wingerchuk, MD Richard Bedlack, MD, PhD Jeffrey Gudin, MD; Jeffrey Bettinger, PharmD Zarazuela Zolkipli-Cunningham, MBChB, MRCP; Mary Kay Koenig, MD; Perry Shieh, MD, PhD,…...

1+ day, 1+ hour ago   (319+ words) The FDA approved Sentynl Therapeutics" copper histidinate for the treatment of pediatric Menkes disease, a rare genetic neurodegenerative disorder, following an earlier complete response letter. Within these studies, 66 patients born after 1999 with severe loss-of-function ATP7A mutations were included in a pooled…...

1+ day, 15+ hour ago   (360+ words) Those from the clinical community may expect to hear data from the registrational trial assessing zorevunersen in Dravet syndrome by mid-2027. Outside of major motor seizure frequency, the study will also assess several secondary outcomes that comprise change in behavior and…...

2+ day, 6+ hour ago   (216+ words) Here's some of what is coming soon to NeurologyLive" this week. Every week, the NeurologyLive" staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will…...

2+ day, 6+ hour ago   (198+ words) Annexon submitted an EMA marketing application for tanruprubart, a first-in-class C1q monoclonal antibody that showed faster and more complete recovery in Guillain-Barr" syndrome patients across randomized trials. Presented by lead author Glenn Morrison, PhD, vice president of clinical development at Annexon…...

3+ day, 1+ hour ago   (324+ words) Test your neurology knowledge with NeurologyLive's weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on epilepsy comorbidities! Welcome to NeurologyLive Brain Games! This weekly quiz series, which goes live every…...

3+ day, 10+ hour ago   (176+ words) Neurology News Network for the week ending January 10, 2025. [WATCH TIME: 4 minutes] WATCH TIME: 4 minutes Welcome to this special edition of Neurology News Network. I'm Marco Meglio. For more direct access to expert insight, head to NeurologyLive.com. This has been…...

3+ day, 14+ hour ago   (175+ words) The chief research officer of the Muscular Dystrophy Association outlined MDA's growing focus on muscle regeneration research and explains why the 2026 MDA Conference is a must-attend meeting for clinicians. [WATCH TIME: 3 minutes] WATCH TIME: 3 minutes | Captions are auto-generated and may…...